P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
Financial Results:
Procter & Gamble Health Ltd reported Revenues for Q1FY24 of ₹301.00 Crores up from ₹296.00 Crore year on year, a rise of 1.69%.
Total Expenses for Q1FY24 of ₹262.00 Crores up from ₹244.00 Crores year on year, a rise of 7.38%.
Consolidated Net Profit of ₹30.00 Crores down 26.83% from ₹41.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹17.96, down 27.61% from ₹24.81 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.